BRIMOTO-50
MRP: 2,090
Packaging: 10x10
Pack Type: tablet
Composition:
Brivaracetam 50mg
Indication:
Epilepsy Most Common Neurological Disorders
Description:
Brivaracetam 50 mg is a prescription antiepileptic drug indicated for the treatment of partial-onset seizures in patients with epilepsy, aged 16 years and older. It is a high-affinity ligand of synaptic vesicle protein 2A (SV2A), which modulates neurotransmitter release and reduces neuronal hyperexcitability.
Compared to older treatments like Levetiracetam, Brivaracetam often offers improved tolerability with fewer behavioral side effects. It is effective both as monotherapy or in adjunctive therapy and has a rapid onset of action.
Tags:
- Controls partial-onset seizures effectively
- Well-tolerated with fewer behavioral side effects
- Can be used as monotherapy or adjunct therapy
- Rapid absorption and brain penetration
- Lower dose option for dose titration or sensitive patients
Usage Information
Dosage
Typical adult starting dose: 50 mg twice daily Maintenance dose: 50–100 mg twice daily (based on clinical response) Can be taken with or without food Dosage adjustments may be necessary in hepatic impairment
Side Effects
Common: Dizziness Fatigue Nausea Drowsiness Irritability Rare/Serious: Suicidal ideation Behavioral changes Hypersensitivity reactions
Contraindications
Known hypersensitivity to Brivaracetam Use with caution in patients with psychiatric disorders Dose adjustment in severe liver impairment may be necessary Not recommended for children under 16 without specialist advice
Availability
Brivaracetam 50mg tablet, epilepsy seizure medication, partial seizures drug, SV2A antiepileptic, Brivaracetam low dose, seizure treatment